echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > A durable model of human germ cell precursors

    A durable model of human germ cell precursors

    • Last Update: 2022-03-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Human PGCLCs have been developed at several research centers, including a laboratory led by Toshi Shioda, MD, at Massachusetts General Hospital (MGH) and the Cancer Research Center at Harvard Medical School
    .

    Natural PGCs exist only in embryos
    .


    These models were created to overcome ethical and technical hurdles surrounding the use of human embryonic tissue in experiments


    "My main interest is to use pgclc for toxicology studies to understand how exposure to chemicals or prescription drugs affects human reproduction,
    " Shioda said.

    He and his colleagues used these cells to study in the lab how chemical exposure in women, such as general anesthesia, causes genetic changes that can be passed on to offspring without causing DNA mutations
    .


    This process is called epigenetics


    They also used the model to study how PGCs turn into testicular cancer, the most common malignancy in boys and young men
    .

    The problem is that hPGCLCs don't survive very long in the lab and lose their germ cell-like characteristics quickly unless they are carefully cared for and treated with serum or added chemicals
    .


    Even if these special cells survive and grow in lab dishes, they deviate from the properties of germ cells and become other types of cells


    But Shioda and colleagues explain reporting in the Journal of Stem Cells that they have developed a method to maintain the germ-cell-like function of hPGCLCs in cell culture without the need for special handling, and the cells survive and continue to replicate for at least five months without losing the original germ- cell-like features


    Using these cells, they have successfully generated hPGCLCs carrying various genetic mutations associated with testicular cancer, and are working to create the first synthetic tumor model of human testicular cancer with well-defined genetic mutations to aid research in cancer prevention and treatment


    This work was supported by endowments from the RICBAC Foundation and the Escher Autism Fund, as well as grants from the National Institutes of Health


    Journal Reference :

    1. Mutsumi Kobayashi, Misato Kobayashi, Junko Odajima, Keiko Shioda, Young Sun Hwang, Kotaro Sasaki, Pranam Chatterjee, Christian Kramme, Richie E.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.